Rapid “epiretinal membrane” development following intravitreal bevacizumab for Coats' disease

Andrew W. Kam, Michelle Hui, Svetlana Cherepanoff, Adrian T. Fung*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    3 Citations (Scopus)
    24 Downloads (Pure)

    Abstract

    Purpose: To report a case of rapid “epiretinal membrane” (“ERM”) development following intravitreal bevacizumab for juvenile Coats' disease. Observations: A 7-year old boy was followed for four years with asymptomatic stage 2 Coats' disease in his left eye. At age 11, he developed symptomatic cystoid macular edema. Argon laser photocoagulation to the leaking aneurysms failed to improve his vision, which had symptomatically declined to 20/30. Four-months after laser, a single injection of intravitreal bevacizumab was given. Rapid development of an “ERM” was noticed on his first post-injection follow-up at 4 weeks. By 8-weeks post-injection the visual acuity had deteriorated to 20/400. 25 + gauge pars plana vitrectomy with “ERM” peeling was performed, with recovery of vision to 20/30 at the 4 months post-operative visit. Conclusions and importance: Intravitreal bevacizumab may induce rapidly progressive “ERM” in patients with juvenile Coats' disease.

    Original languageEnglish
    Pages (from-to)75-77
    Number of pages3
    JournalAmerican Journal of Ophthalmology Case Reports
    Volume11
    DOIs
    Publication statusPublished - 1 Sep 2018

    Bibliographical note

    Copyright the Author(s) 2018. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

    Keywords

    • Coats disease
    • Epiretinal membrane
    • Intravitreal bevacizumab

    Fingerprint

    Dive into the research topics of 'Rapid “epiretinal membrane” development following intravitreal bevacizumab for Coats' disease'. Together they form a unique fingerprint.

    Cite this